{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:43:52Z","timestamp":1789173832235,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jingmen City Science and Technology Project","award":["2018YFYB023"],"award-info":[{"award-number":["2018YFYB023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00223-020-00804-1","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:28:39Z","timestamp":1610584119000},"page":"798-807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Iron Sucrose: A Double-Edged Sword in High Phosphate Media-Induced Vascular Calcification"],"prefix":"10.1007","volume":"108","author":[{"given":"Ping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengkun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangshan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7419-5929","authenticated-orcid":false,"given":"Dan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"804_CR1","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","volume":"18","author":"GM London","year":"2003","unstructured":"London GM, Guerin AP, Marchais SJ et al (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transpl 18:1731\u20131740","journal-title":"Nephrol Dial Transpl"},{"key":"804_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10157-011-0517-y","volume":"15","author":"M Ohya","year":"2011","unstructured":"Ohya M, Otain H, Kimura K et al (2011) Vascular calcification estimated by aortic calcification area index is significant predictive parameter of cardiovascular mortality in hemodialysis patients. Clin Exp Nephrol 15:877\u2013883","journal-title":"Clin Exp Nephrol"},{"key":"804_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1681\/ASN.2008070692","volume":"20","author":"M Mizobuchi","year":"2009","unstructured":"Mizobuchi M, Tower D, Slatopolsky E (2009) Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 20:1453\u20131464","journal-title":"J Am Soc Nephrol"},{"key":"804_CR4","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1097\/01.ASN.0000145894.57533.C4","volume":"15","author":"CM Giachelli","year":"2004","unstructured":"Giachelli CM (2004) Vascular calcification mechanisms. J Am Soc Nephrol 15:2959\u20132964","journal-title":"J Am Soc Nephrol"},{"key":"804_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","volume":"109","author":"CM Shanahan","year":"2011","unstructured":"Shanahan CM, Crouthamel MH, Kapustin A et al (2011) Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 109:697\u2013711","journal-title":"Circ Res"},{"key":"804_CR6","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1253\/circj.CJ-14-0735","volume":"78","author":"P Gross","year":"2014","unstructured":"Gross P, Six I, Kamel S, Massy ZA (2014) Vascular toxicity of phosphate in chronic kidney disease: beyond vascular calcification. Circ J 78:2339\u20132346","journal-title":"Circ J"},{"key":"804_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1681\/ASN.2011121191","volume":"24","author":"R Shroff","year":"2013","unstructured":"Shroff R, Long DA, Shanahan C (2013) Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol 24:179\u2013189","journal-title":"J Am Soc Nephrol"},{"key":"804_CR8","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2011111078","volume":"23","author":"JL Babitt","year":"2012","unstructured":"Babitt JL, Lin HY (2012) Mechanisms of anemia in CKD. J Am Soc Nephrol 23:1631\u20131634","journal-title":"J Am Soc Nephrol"},{"key":"804_CR9","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl, 2012;2:279\u2013335."},{"issue":"5","key":"804_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1053\/j.ajkd.2016.04.018","volume":"68","author":"D Shepshelovich","year":"2016","unstructured":"Shepshelovich D, Rozen-Zvi B, Avni T et al (2016) Intravenous versus oral iron supplementation for the treatment of anemia in CKD: an updated systematic review and meta-analysis. Am J Kidney Dis 68(5):677\u2013690","journal-title":"Am J Kidney Dis"},{"key":"804_CR11","first-page":"9","volume":"7","author":"IC Macdougall","year":"2013","unstructured":"Macdougall IC, Geisser P (2013) Use of intravenous iron supplementation in chronic kidney disease: an update. Iran J Kidney Dis 7:9\u201322","journal-title":"Iran J Kidney Dis"},{"key":"804_CR12","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1681\/ASN.2014090922","volume":"26","author":"DM Charytan","year":"2015","unstructured":"Charytan DM, Pai AB, Chan CT et al (2015) Dialysis advisory group of the American society of nephrology. Considerations and challenges in defining optimal iron utilization in hemodialysis. J Am Soc Nephrol 26:1238\u20131247","journal-title":"J Am Soc Nephrol"},{"key":"804_CR13","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1093\/ndt\/gft062","volume":"28","author":"GR Bailie","year":"2013","unstructured":"Bailie GR, Larkina M, Goodkin DA et al (2013) Variation in intravenous iron use internationally and over time: the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transpl 28:2570\u20132579","journal-title":"Nephrol Dial Transpl"},{"key":"804_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.kint.2015.10.002","volume":"89","author":"IC Macdougall","year":"2016","unstructured":"Macdougall IC, Bircher AJ, Eckardt KU et al (2016) Iron management in chronic kidney disease: conclusions from a \u201cKidney disease: improving global outcomes\u201d (KDIGO) controversies conference. Kidney Int 89:28\u201339","journal-title":"Kidney Int"},{"key":"804_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/ckj\/sfv142","volume":"9","author":"L Del Vecchio","year":"2016","unstructured":"Del Vecchio L, Longhi S, Locatelli F (2016) Safety concerns about intravenous iron therapy in patients with chronic kidney disease. Clin Kidney J 9:260\u2013267","journal-title":"Clin Kidney J"},{"key":"804_CR16","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1224577","volume":"338","author":"H Drakesmith","year":"2012","unstructured":"Drakesmith H, Prentice AM (2012) Hepcidin and the iron-infection axis. Science 338:768\u2013772","journal-title":"Science"},{"key":"804_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/08860220802599106","volume":"31","author":"A Ganguli","year":"2009","unstructured":"Ganguli A, Kohli HS, Khullar M, Lal Gupta K, Jha V, Sakhuja V (2009) Lipid peroxidation products formation with various intravenous iron preparations in chronic kidney disease. Ren Fail 31:106\u2013110","journal-title":"Ren Fail"},{"issue":"4","key":"804_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10534-015-9845-9","volume":"28","author":"S Neiser","year":"2015","unstructured":"Neiser S, Rentsch D, Dippon U et al (2015) Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose. Biometals 28(4):615\u2013635","journal-title":"Biometals"},{"issue":"7","key":"804_CR19","first-page":"354","volume":"65","author":"JE Toblli","year":"2015","unstructured":"Toblli JE, Cao G, Giani JF, Dominici FP, Angerosa M (2015) Nitrosative stress and apoptosis by intravenous ferumoxytol, iron isomaltoside 1000, iron dextran, iron sucrose, and ferric carboxymaltose in a nonclinical model. Drug Res (Stuttg) 65(7):354\u2013360","journal-title":"Drug Res (Stuttg)"},{"issue":"4","key":"804_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.5414\/CN109512","volume":"91","author":"IC Macdougall","year":"2019","unstructured":"Macdougall IC, Strauss WE, Dahl NV et al (2019) Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial. Clin Nephrol 91(4):237\u2013245","journal-title":"Clin Nephrol"},{"issue":"4","key":"804_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000493551","volume":"48","author":"IC Macdougall","year":"2018","unstructured":"Macdougall IC, White C, Anker SD et al (2018) Randomized trial comparing proactive, high-dose versus reactive, low-dose intravenous iron supplementation in hemodialysis (PIVOTAL): study design and baseline data. Am J Nephrol 48(4):260\u2013268","journal-title":"Am J Nephrol"},{"issue":"5","key":"804_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJMoa1810742","volume":"380","author":"IC Macdougall","year":"2019","unstructured":"Macdougall IC, White C, Anker SD et al (2019) Intravenous iron in patients undergoing maintenance hemodialysis. N Engl J Med 380(5):447\u2013458","journal-title":"N Engl J Med"},{"issue":"2","key":"804_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40620-014-0046-3","volume":"27","author":"T Seto","year":"2014","unstructured":"Seto T, Hamada C, Tomino Y (2014) Suppressive effects of iron overloading on vascular calcification in uremic rats. J Nephrol 27(2):135\u2013142","journal-title":"J Nephrol"},{"key":"804_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2016.09.071","volume":"254","author":"P Ciceri","year":"2016","unstructured":"Ciceri P, Elli F, Braidotti P et al (2016) Iron citrate reduces high phosphate-induced vascular calcification by inhibiting apoptosis. Atherosclerosis 254:93\u2013101","journal-title":"Atherosclerosis"},{"key":"804_CR25","doi-asserted-by":"publisher","first-page":"515606","DOI":"10.1155\/2015\/515606","volume":"2015","author":"O Phan","year":"2015","unstructured":"Phan O, Maillard M, Malluche HH et al (2015) Effects of sucroferric oxyhydroxide compared to lanthanum carbonate and sevelamer carbonate on phosphate homeostasis and vascular calcifications in a rat model of chronic kidney failure. Biomed Res Int 2015:515606","journal-title":"Biomed Res Int"},{"issue":"5","key":"804_CR26","first-page":"3622","volume":"19","author":"P Wang","year":"2019","unstructured":"Wang P, Quan ZL, Luo DS et al (2019) Spironolactone dose-dependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit-1. Mol Med Rep 19(5):3622\u20133632","journal-title":"Mol Med Rep"},{"key":"804_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"804_CR28","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","volume":"117","author":"L Demer","year":"2008","unstructured":"Demer L, Tintut Y (2008) Vascular calcification: pathobiology of a multifaceted disease. Circulation 117:2938\u20132948","journal-title":"Circulation"},{"key":"804_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ki.2008.130","volume":"74","author":"K Hruska","year":"2008","unstructured":"Hruska K, Mathew S, Lund R et al (2008) Hyperphosphatemia of chronic kidney disease. Kidney Int 74:148\u2013157","journal-title":"Kidney Int"},{"key":"804_CR30","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/ajh\/hpu225","volume":"28","author":"M Agharazii","year":"2015","unstructured":"Agharazii M, St-Louis R, Gautier-Bastien A et al (2015) Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification. Am J Hypertens 28:746\u2013755","journal-title":"Am J Hypertens"},{"key":"804_CR31","doi-asserted-by":"publisher","first-page":"15319","DOI":"10.1074\/jbc.M800021200","volume":"283","author":"CH Byon","year":"2008","unstructured":"Byon CH, Javed A, Dai Q et al (2008) Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 283:15319\u201315327","journal-title":"J Biol Chem"},{"key":"804_CR32","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/ndt\/gfq858","volume":"26","author":"E Neven","year":"2011","unstructured":"Neven E, De Schutter TM, Behets GJ et al (2011) Iron and vascular calcification: is there a link? Nephrol Dial Transpl 26:1137\u20131145","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"804_CR33","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41598-017-19092-1","volume":"8","author":"S Kawada","year":"2018","unstructured":"Kawada S, Nagasawa Y, Kawabe M et al (2018) Iron-induced calcification in human aortic vascular smooth muscle cells through interleukin-24 (IL-24), with\/without TNF-alpha. Sci Rep 8(1):658","journal-title":"Sci Rep"},{"key":"804_CR34","doi-asserted-by":"publisher","first-page":"e50295","DOI":"10.1371\/journal.pone.0050295","volume":"7","author":"KL Kuo","year":"2012","unstructured":"Kuo KL, Hung SC, Lin YP et al (2012) Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients. PLoS ONE 7:e50295","journal-title":"PLoS ONE"},{"issue":"4","key":"804_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10534-011-9409-6","volume":"24","author":"AB Pai","year":"2011","unstructured":"Pai AB, Conner T, McQuade CR et al (2011) Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose. Biometals 24(4):603\u2013613","journal-title":"Biometals"},{"key":"804_CR36","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.freeradbiomed.2013.09.001","volume":"65","author":"TS Koskenkorva-Frank","year":"2013","unstructured":"Koskenkorva-Frank TS, Weiss G, Koppenol WH et al (2013) The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med 65:1174\u20131194","journal-title":"Free Radic Biol Med"},{"key":"804_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2369-11-16","volume":"11","author":"A Gupta","year":"2010","unstructured":"Gupta A, Zhuo J, Zha J et al (2010) Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival. BMC Nephrol 11:16","journal-title":"BMC Nephrol"},{"key":"804_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijcard.2016.03.039","volume":"212","author":"JE Toblli","year":"2016","unstructured":"Toblli JE, Cao G, Rivas C et al (2016) Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative\/nitrosative stress and inflammation. Int J Cardiol 212:84\u201391","journal-title":"Int J Cardiol"},{"key":"804_CR39","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.2147\/DDDT.S132612","volume":"11","author":"JE Toblli","year":"2017","unstructured":"Toblli JE, Cao G, Giani JF, Dominici FP, Angerosa M (2017) Markers of oxidative\/nitrosative stress and inflammation in lung tissue of rats exposed to different intravenous iron compounds. Drug Des Devel Ther 11:2251\u20132263","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"804_CR40","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.kint.2016.05.020","volume":"90","author":"S Mokas","year":"2016","unstructured":"Mokas S, Larivi\u00e8re R, Lamalice L et al (2016) Hypoxia-inducible factor-1 plays a role in phosphate-induced vascular smooth muscle cell calcification. Kidney Int 90(3):598\u2013609","journal-title":"Kidney Int"},{"key":"804_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin","year":"2008","unstructured":"Kaelin WG, Ratcliffe PJ (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30:393\u2013402","journal-title":"Mol Cell"},{"key":"804_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrm1366","volume":"5","author":"CJ Schofield","year":"2004","unstructured":"Schofield CJ, Ratcliffe PJ (2004) Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5:343\u2013354","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"804_CR43","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1681\/ASN.V133734","volume":"13","author":"HI Feldman","year":"2002","unstructured":"Feldman HI, Santanna J, Guo W et al (2002) Iron administration and clinical outcomes in hemodialysis patients. J Am Soc Nephrol 13(3):734\u2013744","journal-title":"J Am Soc Nephrol"},{"key":"804_CR44","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1097\/01.ASN.0000128009.69594.BE","volume":"15","author":"HI Feldman","year":"2004","unstructured":"Feldman HI, Joffe M, Robinson B et al (2004) Administration of parenteral iron and mortality among hemodialysis patients. J Am Soc Nephrol 15:1623\u20131632","journal-title":"J Am Soc Nephrol"},{"key":"804_CR45","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1681\/ASN.2005040423","volume":"16","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K, Regidor DL, McAllister CJ et al (2005) Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol 16:3070\u20133080","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"804_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12185-008-0120-5","volume":"88","author":"Y Kohgo","year":"2008","unstructured":"Kohgo Y, Ikuta K, Ohtake T et al (2008) Body iron metabolism and pathophysiology of iron overload. Int J Hematol 88(1):7\u201315","journal-title":"Int J Hematol"},{"issue":"47","key":"804_CR47","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1093\/eurheartj\/ehw122","volume":"37","author":"A Laguna-Fernandez","year":"2016","unstructured":"Laguna-Fernandez A, Carracedo M, Jeanson G et al (2016) Iron alters valvular interstitial cell function and is associated with calcification in aortic stenosis. Eur Heart J 37(47):3532\u20133535","journal-title":"Eur Heart J"},{"issue":"3","key":"804_CR48","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tmrv.2020.07.002","volume":"34","author":"I Bellos","year":"2020","unstructured":"Bellos I, Frountzas M, Pergialiotis V (2020) Comparative risk of hypophosphatemia following the administration of intravenous iron formulations: a network meta-analysis. Transfus Med Rev 34(3):188\u2013194","journal-title":"Transfus Med Rev"},{"issue":"1","key":"804_CR49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000487368","volume":"43","author":"K Muras-Szwedziak","year":"2018","unstructured":"Muras-Szwedziak K, Nowicki M (2018) Associations between intravenous iron, inflammation and FGF23 in non-dialysis patients with chronic kidney disease stages 3\u20135. Kidney Blood Press Res 43(1):143\u2013151","journal-title":"Kidney Blood Press Res"},{"issue":"9","key":"804_CR50","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ajh.25564","volume":"94","author":"M Auerbach","year":"2019","unstructured":"Auerbach M, Henry D, Derman RJ et al (2019) A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial. Am J Hematol 94(9):1007\u20131014","journal-title":"Am J Hematol"},{"issue":"1","key":"804_CR51","first-page":"863","volume":"17","author":"P Wang","year":"2019","unstructured":"Wang P, Zhou P, Chen W et al (2019) Combined effects of hyperphosphatemia and hyperglycemia on the calcification of cultured human aortic smooth muscle cells. Exp Ther Med 17(1):863\u2013868","journal-title":"Exp Ther Med"},{"key":"804_CR52","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/hh2401.101070","volume":"89","author":"SA Steitz","year":"2001","unstructured":"Steitz SA, Speer MY, Curinga G et al (2001) Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbf\u02511 and downregulation of smooth muscle lineage markers. Circ Res 89:1147\u20131154","journal-title":"Circ Res"},{"issue":"1","key":"804_CR53","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00467-013-2575-8","volume":"29","author":"PR Srivaths","year":"2014","unstructured":"Srivaths PR, Goldstein SL, Krishnamurthy R et al (2014) High serum\u00a0phosphorus\u00a0and FGF 23 levels are\u00a0associated\u00a0with progression of\u00a0coronary\u00a0calcifications. Pediatr Nephrol 29(1):103\u2013109","journal-title":"Pediatr Nephrol"},{"key":"804_CR54","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/ki.2009.83","volume":"75","author":"MM El-Abbadi","year":"2009","unstructured":"El-Abbadi MM, Pai AS, Leaf EM et al (2009) Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int 75:1297\u20131307","journal-title":"Kidney Int"},{"issue":"2","key":"804_CR55","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2215\/CJN.05420709","volume":"5","author":"RB Oliveira","year":"2010","unstructured":"Oliveira RB, Cancela AL, Graciolli FG et al (2010) Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin J Am Soc Nephrol 5(2):286\u2013291","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"804_CR56","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/01.RES.0000216409.20863.e7","volume":"98","author":"X Li","year":"2006","unstructured":"Li X, Yang H, Giachelli CM (2006) Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 98(7):905\u2013912","journal-title":"Circ Res"},{"key":"804_CR57","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1160\/TH09-12-0814","volume":"104","author":"WL Lau","year":"2010","unstructured":"Lau WL, Festing MH, Giachelli CM (2010) Phosphate and vascular calcification: emerging role of the sodium-dependent phosphate cotransporter Pit-1. Thromb Haemost 104:464\u2013470","journal-title":"Thromb Haemost"},{"issue":"11","key":"804_CR58","first-page":"E357","volume":"9","author":"S Scialla","year":"2020","unstructured":"Scialla S, Palazzo B, Sannino A et al (2020) Evidence of modular responsiveness of osteoblast-like cells exposed to hydroxyapatite-containing magnetic nanostructures. Biol (Basel) 9(11):E357","journal-title":"Biol (Basel)"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00804-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-020-00804-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00804-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T04:04:12Z","timestamp":1674878652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-020-00804-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["804"],"URL":"https:\/\/doi.org\/10.1007\/s00223-020-00804-1","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"7 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Ping Wang, Chengkun Guo, Hui Pan, Wangshan Chen and Dan Peng declares that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was granted by the Ethical Committee of the\u00a0First\u00a0People's\u00a0Hospital\u00a0of\u00a0Jingmen (Jingmen, China) and the study protocols conformed to the National institute of Health (NIH) guidelines for the care and use of laboratory animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}